| EXPECTED EXPERIMENT
RESULTS |
CPCF-2,
GCF,
SPC |
X-ray
analysis data of protein crystals will be used to develop
new-generation medicines. |
| MIMETIK-K |
Develop new generation of medical product. |
| ESCD |
An evaluation of space flight factors impact on the
viability and development of embryonic and stem cells. |
| VITAMIN
D |
Investigation
of effect of microgravity on the mechanism of action
of Vitamin D in osteoblasts. |
| RHOSIGNAL |
Effect
of microgravity on GTPases of the Rhosig family (Rho
GTPases) in human fibroblasts. |
| RAMIROS |
Mammalian
oxidative stress caused by effect of space radiation
and microgravity. |
|
MESSAGE, MESSAGE-2 |
Expression
(evolution) of microbial genes in space flight. |
| GCF-B |
Protein
crystallization |
| PROMISS,
PROMISS-2, PROMISS-3 |
Protein
Crystal Growth Monitoring by Digital Holographic Microscope. |
| BIODEGRADATION |
Development
of biological safety assurance techniques for spacecraft. |
| CONJUGATION |
Development
test of genetic material transfer process by the method
of bacterial conjugation. |
| MSK |
Behavior
of mesenchymal truncal cells from bone marrow during
space flight. |
| KAF |
Crystallization
of protein Caf 1M and its complex with C-end peptide
Caf1 as a basis for designing a new generation of antimicrobial
medicines and vaccine components against yersinioses. |
| VAKTSINA-K |
Structural
investigation of proteins-candidates for vaccines against
AIDS under the ground and space conditions. |
| BIOEKOLOGIA |
Production
of highly efficient strains of microorganisms for the
manufacture of the preparations resulting from oil biodegradation,
plant protection means, as well as exopolysaccharides
used in oil industry. |
| INTERLEUKIN-K |
Production
of high-quality crystals of interleukins-1 α,
-1 β and receptor antagonist of interleukin-1. |
| SAMPLE |
Molecular
and physiological analysis of bacterial samples isolated
from the ISS. |
| BIOEMULSIA |
Study
and test of the autonomous reactor of the closed
type to produce biomass of microorganisms and biologically
active substances without introduction of additional
ingredients and removal of metabolic products, development
of new moderate-stage and highly efficient technologies
on its basis to produce drug preparations. |
| GLIDOPROTEID |
Extraction
and study of surface glycoproteins E1-E2 of alpha
viruses in the Earth and space conditions. |
| BIOTRACK |
Investigation of impact of space radiation heavy charged particle fluxes
on genetic properties of cell producers. |
| ANTIGEN |
Optimization of heterological expression in yeast-saccharomycetes in microgavity by the example of HBS hepatitis B virus antigen synthesis. |
| LACTOLEN |
Effects of space flight
environment on the lactolen producer strain. |
| ARIL |
Effects of space flight
environment on the expression of strains producing interleukins 1α,
1β, aryl. |
| OChB |
Effects of space flight
environment on the superoxide dismutase producer strain. |
| ASTROVAKCINA |
Cultivation in zero gravity
of an E. Coli producer of the Caf1 protein. |
| ZHENSHEN-2 |
A study of the possibility
to increase the biological activity of ginseng. |
| CIS |
Cells In Space. |
| MIS |
Investigation of the effects of spaceflight on gene expression profiles of E. Cloacae
and Acinetobacter baumanii. |
| PCS |
Protein Crystallization
in Space. |
| PCG |
Protein crystallization in microgravity environment. |
| KASKAD |
Investigation of different types of cell cultivation. |
| BIF |
Investigation of space flight factors effect on technological and biomedical characteristics of bifidobacteria. |
| BACTERIOPHAGE |
Investigation of space flight factors effect on bacteriophages. |
| STRUKTURA |
Obtain high-quality protein monocrystals. |
| KONSTANTA |
Investigation of space flight factors effect on enzymatic activity . |
| CG |
Protein and inorganic substance crystallization in microgravity environment. |
